Overexpression of circ PTK2 suppresses the progression of nonalcoholic fatty liver disease via the miR‐200c/SIK2/PI3K/Akt axis
Authors:
Open Access
- 6 July 2022
- journal article
- research article
- Published by Wiley in The Kaohsiung Journal of Medical Sciences
- Vol. 38 (9) , 869-878
Abstract
Excessive hepatic lipid accumulation is involved in the pathogenesis of nonalcoholic fatty liver disease (NAFLD). A previous study showed that the circular RNA (circRNA) PTK2 was significantly downregulated in NAFLD mice. However, the detailed function of circ PTK2 in NAFLD remains unclear. A high‐fat diet (HFD) was used to establish a mouse model of NAFLD, and free fatty acid (FFA) treatment was used to establish an in vitro model of NAFLD. Oil red O staining was used to evaluate lipid accumulation. The pathological changes in mice were observed by HE staining. Western blotting and RT–qPCR were applied to assess protein and mRNA levels, respectively. A dual luciferase reporter assay and RIP were used to explore the relationship among circ PTK2, miR‐200c and SIK2. Circ PTK2 and SIK2 were downregulated and miR‐200c was upregulated in NAFLD. Upregulation of circ PTK2 reversed lipid accumulation in FFA‐treated HepG2 cells. Moreover, circ PTK2 bound to miR‐200c, and SIK2 was identified as the direct target of miR‐200c. Moreover, the miR‐200c inhibitor‐induced decrease in lipid accumulation was reversed by SIK2 knockdown. Furthermore, the impact of circ PTK2 overexpression on PI3K/Akt signaling was partially reversed by SIK2 silencing. Circ PTK2 overexpression alleviates NAFLD development via the miR‐200c/SIK2/PI3K/Akt axis. Thus, our work might provide new methods for NAFLD treatment.Keywords
This publication has 39 references indexed in Scilit:
- Integrated analysis of hepatic mRNA and miRNA profiles identified molecular networks and potential biomarkers of NAFLDScientific Reports, 2018
- SIK2 attenuates proliferation and survival of breast cancer cells with simultaneous perturbation of MAPK and PI3K/Akt pathwaysOncotarget, 2018
- circRNA_0046366 inhibits hepatocellular steatosis by normalization of PPAR signalingWorld Journal of Gastroenterology, 2018
- Loss of miR-141/200c ameliorates hepatic steatosis and inflammation by reprogramming multiple signaling pathways in NASHJCI Insight, 2017
- circRNA_0046367 Prevents Hepatoxicity of Lipid Peroxidation: An Inhibitory Role against Hepatic SteatosisOxidative Medicine and Cellular Longevity, 2017
- NAFLD and Chronic Kidney DiseaseInternational Journal of Molecular Sciences, 2016
- NAFLD: A multisystem diseaseJournal of Hepatology, 2015
- Targeting PI3K/AKT/mTOR network for treatment of leukemiaCellular and Molecular Life Sciences, 2015
- Salt-inducible kinase 2 links transcriptional coactivator p300 phosphorylation to the prevention of ChREBP-dependent hepatic steatosis in miceJournal of Clinical Investigation, 2010
- Isolation and Culture of Adult Mouse Hepatocytes2010